Phio Pharmaceuticals
PHIO | NASDAQ
$0.75
-$0.02 (-2.72%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
+$0.02 (+2.80%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.72%
(1D)No price chart data available for 1D timeframe.
Rating
29.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #812/1021 (Top 80%)
Key Statistics
Market Data
Market Cap $8.99M
1D Range
0.72 0.77
52W Range
0.72 1.65
Valuation (TTM)
PE -0.60
PB 1.04
EV/EBITDA 0.15
Valuation (NTM)
Forward PE N/A
Forward PEG 0.10
Price Target $14.00
Cash Flow
FCF Yield -137.9%
SBC Adj. FCF Yield -147.7%
SBC Impact -7.1%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 0.1% |
-49.5%
FCF 3Y | 5Y -23.1% |
3.0%
Returns
ROA -129.7%
ROE -101.5%
ROIC -176.8%
Financial Health
Net Cash
$10.61M
Current Ratio 4.19
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designe...
Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date May 10, 2012
Website www.phiopharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$14.00
Upside
+1766.67%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PHIO